Caterina Patti

6.3k total citations · 1 hit paper
75 papers, 1.7k citations indexed

About

Caterina Patti is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Caterina Patti has authored 75 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Pathology and Forensic Medicine, 28 papers in Oncology and 26 papers in Genetics. Recurrent topics in Caterina Patti's work include Lymphoma Diagnosis and Treatment (62 papers), Chronic Lymphocytic Leukemia Research (23 papers) and CNS Lymphoma Diagnosis and Treatment (15 papers). Caterina Patti is often cited by papers focused on Lymphoma Diagnosis and Treatment (62 papers), Chronic Lymphocytic Leukemia Research (23 papers) and CNS Lymphoma Diagnosis and Treatment (15 papers). Caterina Patti collaborates with scholars based in Italy, United States and France. Caterina Patti's co-authors include Andrea Gallamini, Luigi Rigacci, Emilio Iannitto, Alessandro Levis, Domenico Albano, Massimo Midiri, Massimo Galia, Simonetta Viviani, Francesco Di Raimondo and Corrado Tarella and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Oncology.

In The Last Decade

Caterina Patti

71 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Early Interim 2-[ ¹⁸ F]Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography Is Prognostically Superior to International Prognostic Score in Advanced-Stage Hodgkin's Lymphoma: A Report From a Joint Italian-Danish Study

2007 552 citations Andrea Gallamini, Martin Hutchings et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Caterina Patti Italy	19	1.4k	608	501	458	358	75	1.7k
Alessandro Broccoli Italy	22	1.2k 0.9×	631 1.0×	264 0.5×	375 0.8×	262 0.7×	116	1.6k
Monica Tani Italy	26	1.7k 1.2×	819 1.3×	459 0.9×	509 1.1×	385 1.1×	105	2.2k
Martina Chiarucci Italy	6	1.3k 0.9×	904 1.5×	284 0.6×	399 0.9×	221 0.6×	10	1.7k
Lorena Appio Italy	4	1.3k 0.9×	885 1.5×	285 0.6×	405 0.9×	220 0.6×	8	1.7k
Gerardo Musuraca Italy	20	1.2k 0.9×	559 0.9×	295 0.6×	304 0.7×	292 0.8×	83	1.7k
Sharlene Litchy United States	15	1.2k 0.9×	1.0k 1.7×	356 0.7×	219 0.5×	300 0.8×	26	1.9k
Annalisa Chiappella Italy	23	1.3k 1.0×	782 1.3×	221 0.4×	506 1.1×	187 0.5×	111	1.7k
M. Dreyling Germany	16	1.2k 0.9×	773 1.3×	123 0.2×	261 0.6×	182 0.5×	22	1.3k
Barbara Botto Italy	19	1.1k 0.8×	571 0.9×	301 0.6×	435 0.9×	288 0.8×	60	1.3k
P. Solal-Céligny France	8	1.2k 0.9×	818 1.3×	165 0.3×	389 0.8×	131 0.4×	14	1.5k

Countries citing papers authored by Caterina Patti

Since Specialization

Citations

This map shows the geographic impact of Caterina Patti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caterina Patti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caterina Patti more than expected).

Fields of papers citing papers by Caterina Patti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caterina Patti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caterina Patti. The network helps show where Caterina Patti may publish in the future.

Co-authorship network of co-authors of Caterina Patti

This figure shows the co-authorship network connecting the top 25 collaborators of Caterina Patti. A scholar is included among the top collaborators of Caterina Patti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caterina Patti. Caterina Patti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sapienza, Giuseppe, Valeria Calafiore, Caterina Patti, et al.. (2024). Sorafenib maintenance after allogeneic stem cell transplantation in patients with FLT3+ AML receiving midostaurin during induction and consolidation: a retrospective analysis. Frontiers in Oncology. 14. 1441254–1441254. 2 indexed citations

Sapienza, Giuseppe, et al.. (2024). Allogeneic Stem Cell Transplantation in Refractory Acute Myeloid Leukaemia. Cells. 13(9). 755–755. 3 indexed citations

Özcan, Muhıt, Eva González‐Barca, Tae Min Kim, et al.. (2024). Waveline-007: Dose Escalation and Confirmation, and Efficacy Expansion Trial of Zilovertamab Vedotin in Combination with Cyclophosphamide, Doxorubicin, and Prednisone Plus Rituximab in Patients with Diffuse Large B Cell Lymphoma. Blood. 144(Supplement 1). 578–578. 1 indexed citations

Castagna, Luca, Roberto Bono, Giuseppe Sapienza, et al.. (2022). The place of allogeneic stem cell transplantation in aggressive B-cell non-Hodgkin lymphoma in the era of CAR-T-cell therapy. Frontiers in Medicine. 9. 1072192–1072192. 1 indexed citations

Albano, Domenico, Giuseppe Micci, Caterina Patti, et al.. (2021). Whole-Body Magnetic Resonance Imaging: Current Role in Patients with Lymphoma. Diagnostics. 11(6). 1007–1007. 7 indexed citations

Phillips, Tycel, Paolo Corradini, Ronit Gurion, et al.. (2020). Phase 2 Study Evaluating the Efficacy and Safety of Parsaclisib in Patients with Relapsed or Refractory Marginal Zone Lymphoma (CITADEL-204). Blood. 136(Supplement 1). 27–28. 16 indexed citations

Cox, Maria Christina, Luigi Marcheselli, Roberta Battistini, et al.. (2019). The metronomic all-oral DEVEC is an effective schedule in elderly patients with diffuse large b-cell lymphoma. Investigational New Drugs. 37(3). 548–558. 11 indexed citations

Galia, Massimo, Domenico Albano, Corrado Tarella, et al.. (2017). Whole body magnetic resonance in indolent lymphomas under watchful waiting: The time is now. European Radiology. 28(3). 1187–1193. 20 indexed citations

Albano, Domenico, Ludovico La Grutta, Emanuele Grassedonio, et al.. (2016). Pitfalls in whole body MRI with diffusion weighted imaging performed on patients with lymphoma: What radiologists should know. Magnetic Resonance Imaging. 34(7). 922–931. 39 indexed citations

10.

Albano, Domenico, Caterina Patti, Ludovico La Grutta, et al.. (2016). Osteonecrosis detected by whole body magnetic resonance in patients with Hodgkin Lymphoma treated by BEACOPP. European Radiology. 27(5). 2129–2136. 26 indexed citations

11.

Galia, Massimo, Domenico Albano, Caterina Patti, et al.. (2016). Whole-body MRI in patients with lymphoma: collateral findings. La radiologia medica. 121(10). 793–800. 20 indexed citations

12.

Gallamini, Andrea, Alessandro Rambaldi, Fontanet Bijou, et al.. (2016). A PHASE 1/2 Clinical Trial of Brentuximab-Vedotin and Bendamustin in Elderly Patients with Previously Untreated Advanced Hodgkin Lymphoma (HALO STUDY. NCT identifier : 02467946): Preliminary Report. Blood. 128(22). 4154–4154. 5 indexed citations

13.

Albano, Domenico, Caterina Patti, Ludovico La Grutta, et al.. (2015). Comparison between whole-body MRI with diffusion-weighted imaging and PET/CT in staging newly diagnosed FDG-avid lymphomas.. European Journal of Radiology. 85(2). 313–318. 59 indexed citations

14.

Rambaldi, Alessandro, Cristina Boschini, Giuseppe Gritti, et al.. (2013). The lymphocyte to monocyte ratio improves the IPI‐risk definition of diffuse large B‐cell lymphoma when rituximab is added to chemotherapy. American Journal of Hematology. 88(12). 1062–1067. 53 indexed citations

15.

Andriani, A, L. Tedeschi, Caterina Patti, et al.. (2008). Management and long-term follow-up of early stage H. pylori-associated gastric MALT-lymphoma in clinical practice: An Italian, multicentre study. Digestive and Liver Disease. 41(7). 467–473. 26 indexed citations

16.

Gallamini, Andrea, Martin Hutchings, Luigi Rigacci, et al.. (2007). Early Interim 2-[ ¹⁸ F]Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography Is Prognostically Superior to International Prognostic Score in Advanced-Stage Hodgkin's Lymphoma: A Report From a Joint Italian-Danish Study. Journal of Clinical Oncology. 25(24). 3746–3752. 552 indexed citations breakdown →

17.

Cortelazzo, Sergio, Michele Magni, Corrado Tarella, et al.. (2007). Update of a GITIL Cohort Study: Frontline High Dose Sequential Chemotherapy with Rituximab and Autologous Stem Cell Transplantation Induces a High Rate of Long-Term Remissions in Patients with Mantle Cell Lymphoma. Blood. 110(11). 1282–1282. 4 indexed citations

18.

Gallamini, Andrea, Francesco Zaja, Livio Gargantini, et al.. (2005). CHOP Chemotherapy Plus Campath-1H (CHOP-C) as First Line Treatment in Patients with Peripheral T-Cell Lymphoma (PTCL).. Blood. 106(11). 3345–3345. 7 indexed citations

19.

Tarella, Corrado, Manuela Zanni, Massimo Di Nicola, et al.. (2005). High CR Rate and Prolonged EFS in aaIPI 2 – 3 Diffuse Large B-Cell Lymphoma Following High-Dose Sequential Chemotherapy and In Vivo Rituximab-Purged Stem Cell Autografting (R-HDS Regimen): Results of a Prospective Phase II Multicenter Study Sponsored by GITIL (Gruppo Italiano Terapie Innovative nei Linfomi).. Blood. 106(11). 2068–2068. 1 indexed citations

20.

Santini, Gino, Cármino Antônio De Souza, Savina Aversa, et al.. (2004). A third generation regimen VACOP-B with or without adjuvant radiotherapy for aggressive localized non-Hodgkin's lymphoma: report from the Italian Non-Hodgkin's Lymphoma Co-operative Study Group. Brazilian Journal of Medical and Biological Research. 37(5). 719–728. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact